Pharmabiz

EMA grants Orphan Drug Designation to Kedrion Biopharma’s plasma-derived treatment for aceruloplasminemia, a rare genetic disorder of iron metabolism

EMA grants Orphan Drug Designation to Kedrion Biopharma’s plasma-derived treatment for aceruloplasminemia, a rare genetic disorder of iron metabolism: Castelvecchio Pascoli, Ita ...
Pharmabiz

Himalaya Wellness partners with Unicommerce to drive omnichannel expansion

Himalaya Wellness partners with Unicommerce to drive omnichannel expansion: Our Bureau, Bengaluru Friday, November 28, 2025, 15:50 Hrs [IST] Himalaya Wellness, has partnered with ...
Pharmabiz

Mercer Marsh Benefits says intense pressure continues on health benefit costs in line with global medical trends

Mercer Marsh Benefits says intense pressure continues on health benefit costs in line with global medical trends: Our Bureau, Bengaluru Friday, November 28, 2025, 15:40 Hrs [IST] ...
Pharmabiz

Medicap Healthcare to raise fresh capital of Rs. 240 crore to expand its role in India’s healthcare packaging market

Medicap Healthcare to raise fresh capital of Rs. 240 crore to expand its role in India’s healthcare packaging market: Our Bureau, Bengaluru Friday, November 28, 2025, 15:20 Hrs ...
Pharmabiz

Cytiva and Veeda Lifesciences drive biopharma innovation with new host cell protein services center

Cytiva and Veeda Lifesciences drive biopharma innovation with new host cell protein services center: Our Bureau, Bengaluru Friday, November 28, 2025, 15:10 Hrs [IST] Cytiva, a Dan ...
Pharmabiz

UK MHRA & NICE receive £2 million from Wellcome to improve safety and effectiveness of digital mental health technologies

UK MHRA & NICE receive £2 million from Wellcome to improve safety and effectiveness of digital mental health technologies: United Kingdom Friday, November 28, 2025, 15:00 Hrs [IS ...
Pharmabiz

Hong Kong Department of Health approves IASO Bio’s’ Fucaso to treat relapsed or refractory multiple myeloma

Hong Kong Department of Health approves IASO Bio’s’ Fucaso to treat relapsed or refractory multiple myeloma: Shanghai, Nanjing Friday, November 28, 2025, 14:00 Hrs [IST] IASO ...
Pharmabiz

Renalys Pharma reports positive results from phase III study of sparsentan in Japanese patients with IgA nephropathy

Renalys Pharma reports positive results from phase III study of sparsentan in Japanese patients with IgA nephropathy: Tokyo, Japan Friday, November 28, 2025, 13:00 Hrs [IST] Renal ...
Pharmabiz

Global pioneer Prof B S Bhoop wins prestigious IPA Eminent Pharmacist Award 2025

Global pioneer Prof B S Bhoop wins prestigious IPA Eminent Pharmacist Award 2025: Our Bureau, Chennai Friday, November 28, ...
Pharmabiz

Cothera Bioscience’s zotiraciclib for treatment of recurrent high-grade glioma receives US FDA fast track designation

Cothera Bioscience’s zotiraciclib for treatment of recurrent high-grade glioma receives US FDA fast track designation: San Mateo, California Friday, November 28, 2025, 12:00 Hrs ...
Pharmabiz

Sun Pharmaceutical’s updated label for Unloxcyt receives US FDA approval

Sun Pharmaceutical’s updated label for Unloxcyt receives US FDA approval: Our Bureau, Mumbai Friday, November 28, 2025, 11:40 Hrs [IST] Sun Pharmaceutical Industries Limited ann ...
Pharmabiz

WHO releases policy brief on priority setting in TB programme planning

WHO releases policy brief on priority setting in TB programme planning: Geneva Friday, November 28, 2025, 11:00 Hrs [IST] The World Health Organization (WHO) has released a new po ...